elotuzumab
FDA Approves Empliciti With Pd for Some Patients With R/R MM
The FDA expanded the indications of elotuzumab (Empliciti, Bristol-Myers Squibb) to include use in combination with ...
NOVEMBER 8, 2018
Long-Term Efficacy and Safety of ELd in RRMM Confirmed
Adding elotuzumab (Empliciti, Bristol-Myers Squibb) to lenalidomide (Revlimid, Celgene) and dexamethasone (ELd) ...
JUNE 26, 2017
Load more